PATENT CLAIM ANALYSIS

Application Number: 15969670
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "004900"]

Abstract:
The invention provides compounds having the general formula I: Y—X—Z   I and salts thereof, wherein the variables X, Y, and Z have the meaning as described herein, and compositions containing such compounds and methods for using such compounds and compositions.

Claim (Index 21):
A method of modulating the activity of a melanocortin receptor homodimer in vitro or in vivo comprising contacting the homodimer with an effective amount of a compound as described in  claim 1 , or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 93.0
- Lexical Diversity: 1.4375
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13320408', '12298826', '15050671', '13074565', '14117949']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7889621052377701
- 35 USC 102 Novelty (BERT): 0.534828091557602
- Combined Prediction Score: 0.7635487038697533
- Mean Citation Score: 352.850674
- Max Citation Score: 377.4124
- Similarity Product: 247.4430239489556

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test